Literature DB >> 15464211

Allodynia in rats infected with varicella zoster virus--a small animal model for post-herpetic neuralgia.

Robert G Dalziel1, Sharon Bingham, David Sutton, Dawn Grant, Jean M Champion, Shelley A Dennis, John P Quinn, Chas Bountra, Margo A Mark.   

Abstract

The most common complication of herpes zoster is post-herpetic neuralgia (PHN), which has been defined as severe pain occurring 1 month after rash onset or persisting for greater than 3 months. PHN is classed as a neuropathic pain that is associated with mechanical allodynia where normally innocuous tactile stimuli are perceived as painful. The development of therapies to treat PHN has been hampered by the lack of animal models, which mimic the clinical situation. We have previously reported that varicella zoster virus (VZV) infection in the rat results in mechanical allodynia and thermal hyperalgesia. Here, we report that following VZV infection of the left footpad rats develop a chronic mechanical allodynia, which is present for longer than 60 days post-infection and which resolves by 100 days PI. The model is robust and reproducible with animals consistently developing allodynia by 3 days PI and continuing to present with symptoms for at least 30 days. The reproducible nature of the induction and course of the allodynia allows the use of this model to determine the effect of various compounds on, and to investigate the pathogenic mechanisms underlying the development of VZV-induced allodynia. Comparative studies using HSV-1 show that the induction of the chronic allodynia is VZV-specific and is not a result is of virus replication-induced tissue damage or accompanying inflammation. Therefore, we propose that the rat VZV infection model could prove useful in studying the mechanisms underlying post-herpetic neuralgia.

Entities:  

Mesh:

Year:  2004        PMID: 15464211     DOI: 10.1016/j.brainresrev.2004.07.008

Source DB:  PubMed          Journal:  Brain Res Brain Res Rev


  29 in total

Review 1.  Herpes zoster and postherpetic neuralgia: past, present and future.

Authors:  Gary J Bennett; C Peter N Watson
Journal:  Pain Res Manag       Date:  2009 Jul-Aug       Impact factor: 3.037

2.  Further characterization of a rat model of varicella zoster virus-associated pain: Relationship between mechanical hypersensitivity and anxiety-related behavior, and the influence of analgesic drugs.

Authors:  F S Hasnie; J Breuer; S Parker; V Wallace; J Blackbeard; I Lever; P R Kinchington; A H Dickenson; T Pheby; A S C Rice
Journal:  Neuroscience       Date:  2006-12-29       Impact factor: 3.590

3.  Two alphaherpesvirus latency-associated gene products influence calcitonin gene-related peptide levels in rat trigeminal neurons.

Authors:  Mohamed A Hamza; Dennis M Higgins; William T Ruyechan
Journal:  Neurobiol Dis       Date:  2006-12-20       Impact factor: 5.996

Review 4.  Rodent models of varicella-zoster virus neurotropism.

Authors:  Jeffrey I Cohen
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

5.  Lateral thalamic control of nociceptive response after whisker pad injection of varicella zoster virus.

Authors:  Phillip R Kramer; Crystal Stinson; Mikhail Umorin; Mohong Deng; Mahesh Rao; Larry L Bellinger; Michael B Yee; Paul R Kinchington
Journal:  Neuroscience       Date:  2017-05-24       Impact factor: 3.590

6.  Neuronal changes induced by Varicella Zoster Virus in a rat model of postherpetic neuralgia.

Authors:  Jean-Marc G Guedon; Michael B Yee; Mingdi Zhang; Stephen A K Harvey; William F Goins; Paul R Kinchington
Journal:  Virology       Date:  2015-04-11       Impact factor: 3.616

7.  Abortive intrabronchial infection of rhesus macaques with varicella-zoster virus provides partial protection against simian varicella virus challenge.

Authors:  Christine Meyer; Flora Engelmann; Nicole Arnold; David L Krah; Jan ter Meulen; Kristen Haberthur; Jesse Dewane; Ilhem Messaoudi
Journal:  J Virol       Date:  2014-11-19       Impact factor: 5.103

Review 8.  Postherpetic neuralgia: from preclinical models to the clinic.

Authors:  Ada Delaney; Lesley A Colvin; Marie T Fallon; Robert G Dalziel; Rory Mitchell; Susan M Fleetwood-Walker
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

9.  The effect of the palmitoylethanolamide analogue, palmitoylallylamide (L-29) on pain behaviour in rodent models of neuropathy.

Authors:  V C J Wallace; A R Segerdahl; D M Lambert; S Vandevoorde; J Blackbeard; T Pheby; F Hasnie; A S C Rice
Journal:  Br J Pharmacol       Date:  2007-06-11       Impact factor: 8.739

10.  Comparison of dorsal root ganglion gene expression in rat models of traumatic and HIV-associated neuropathic pain.

Authors:  Klio Maratou; Victoria C J Wallace; Fauzia S Hasnie; Kenji Okuse; Ramine Hosseini; Nipurna Jina; Julie Blackbeard; Timothy Pheby; Christine Orengo; Anthony H Dickenson; Stephen B McMahon; Andrew S C Rice
Journal:  Eur J Pain       Date:  2008-07-07       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.